中华临床免疫和变态反应杂志2016，Vol.10Issue(4)：407-411,5.DOI:10.3969/j.issn.1673-8705.2016.04.017
慢性自发性荨麻疹药物治疗进展
Progress on Pharmacotherapy of Chronic Spontaneous Urticaria
赵文玲 1刘艺迪 1王亚男 1吴遐 1李丽1
作者信息
- 1. 中国医学科学院 北京协和医学院 北京协和医院皮肤科，北京100730
- 折叠
摘要
Abstract
Chronic spontaneous urticaria is a common cutaneous disorder , but the underlying pathogenesis is complex and the efficacy of therapy is unsatisfactory .The first-line therapy for this disorder is antihistamine , of which the second-generation non-sedative products should be given as priority and the first-generation should be avoided . In addition , doubling the dosage can efficaciously relieve urticarial symptoms .Leukotriene receptor antagonist combined with antihistamine has remarkable efficacy for the treatment of urticaria .Cyclosporin can be only administered when the first-line and second-line treatments failed , and the duration should be no more than three months .Omalizumab can effectively control symptoms of chronic spontaneous urticaria under the recom -mended dose of 300 mg per four weeks;however , attention should be paid to its side effects closely .关键词
荨麻疹/慢性/自发性/药物/治疗Key words
urticaria/chronic/spontaneous/pharmacotherapy分类
医药卫生引用本文复制引用
赵文玲,刘艺迪,王亚男,吴遐,李丽..慢性自发性荨麻疹药物治疗进展[J].中华临床免疫和变态反应杂志,2016,10(4):407-411,5.
